Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient
Mucormycosis is a life threatening infection caused by fungi in the order Mucorales. Mucormycosis can affect any organ system with rhino-orbital-cerebral and pulmonary infections being the most predominant infection types. Gastrointestinal mucormycosis is rare and accounts for only 4–7% of all cases...
Main Authors: | Anthony Anderson, Dayna McManus, Sarah Perreault, Ying-Chun Lo, Stuart Seropian, Jeffrey E. Topal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Medical Mycology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211753917300210 |
Similar Items
-
Bronchoscopic instillation of amphotericin B is a safe and effective measure to treat pulmonary mycosis
by: Lei Yang, et al.
Published: (2023-06-01) -
In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales
by: Gaia Ortalli, et al.
Published: (2023-07-01) -
Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01) -
Liposomal amphotericin B and leishmaniasis: Dose and response
by: Shyam Sundar, et al.
Published: (2010-01-01) -
Methods for particle size reduction of liposomal amphotericin B
by: Tuan Quang Nguyen, et al.
Published: (2018-03-01)